Evidence map›Paper›PMID 33510154›Full record

ArticleScientific data2021

A patient-centric dataset of images and metadata for identifying melanomas using clinical context.

Veronica Rotemberg, Nicholas Kurtansky, Brigid Betz-Stablein, Liam Caffery, Emmanouil Chousakos, Noel Codella, Marc Combalia, Stephen Dusza, Pascale Guitera, David Gutman and 15 more

Erratum issuedAbstract readDataset
In one paragraph

Article in Scientific data, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. DermIDS: Dermatology imaging data structure for scalable and interoperable AI systems.Proceedings of SPIE--the International Society for Optical Engineering · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Veronica Rotemberg *Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. rotembev@mskcc.org.ORCID http://orcid.org/0000-0003-0639-2677
Nicholas Kurtansky *Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Brigid Betz-StableinThe University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia.ORCID http://orcid.org/0000-0003-3876-501X
Liam CafferyThe University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia.
Emmanouil ChousakosDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-8127-4761
Noel CodellaMicrosoft, Redmond, WA, USA.
Marc CombaliaMelanoma Unit, Dermatology Department, Hospital Cĺınic Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain.
Stephen DuszaDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pascale GuiteraMelanoma Institute Australia and Sydney Melanoma Diagnostic Center, Sydney, Australia.
David GutmanEmory University School of Medicine, Department of Biomedical Informatics, Atlanta, GA, USA.
Allan HalpernDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Brian HelbaKitware, Inc., Clifton Park, NY, USA.
Harald KittlerMedical University of Vienna, Department of Dermatology, Vienna, Austria.ORCID http://orcid.org/0000-0002-0051-8016
Kivanc KoseDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-3185-2639
Steve LangerDivision of Radiology Informatics, Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Konstantinos LioprysUniversity of Athens Medical School, Athens, Greece.
Josep MalvehyMelanoma Unit, Dermatology Department, Hospital Cĺınic Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain.
Shenara MusthaqDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jabpani NandaDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ofer ReiterDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
George ShihDepartment of Radiology, Weill Cornell Medical College, New York, NY, USA.
Alexander StratigosUniversity of Athens Medical School, Athens, Greece.
Philipp TschandlMedical University of Vienna, Department of Dermatology, Vienna, Austria.ORCID http://orcid.org/0000-0003-0391-7810
Jochen WeberDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
H Peter SoyerThe University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia.ORCID http://orcid.org/0000-0002-4770-561X

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Australian Cancer Research Foundation (ACRF) Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID)Department of Health | National Health and Medical Research Council (NHMRC) APP1099021Melanoma Research Alliance (MRA) Young Investigator Award 614197NCI NIH HHS P30 CA008748U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIH/NCI Cancer Center Support Grant P30 CA008748
6 · The paper itself

Abstract

Prior skin image datasets have not addressed patient-level information obtained from multiple skin lesions from the same patient. Though artificial intelligence classification algorithms have achieved expert-level performance in controlled studies examining single images, in practice dermatologists base their judgment holistically from multiple lesions on the same patient. The 2020 SIIM-ISIC Melanoma Classification challenge dataset described herein was constructed to address this discrepancy between prior challenges and clinical practice, providing for each image in the dataset an identifier allowing lesions from the same patient to be mapped to one another. This patient-level contextual information is frequently used by clinicians to diagnose melanoma and is especially useful in ruling out false positives in patients with many atypical nevi. The dataset represents 2,056 patients (20.8% with at least one melanoma, 79.2% with zero melanomas) from three continents with an average of 16 lesions per patient, consisting of 33,126 dermoscopic images and 584 (1.8%) histopathologically confirmed melanomas compared with benign melanoma mimickers.

Indexed as

MelanomaSkin NeoplasmsArtificial IntelligenceHumansMetadataSkin

Identifiers

PMID33510154
PMCPMC7843971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.